Skip to main content
logo
QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
28.42
+1.11 (4.06%)
Oct 16, 2025, 4:00 PM EDT - Market closed

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2021
Period Ending
Jun '25 Dec '24 Dec '23 Jan '23 Jan '22 2014 - 2021
North America Revenue
1.55B1.62B
Log In
Log In
Log In
Upgrade
EMEA Revenue
346.10M335.80M
Log In
Log In
Log In
Upgrade
China Revenue
325.70M325.00M
Log In
Log In
Log In
Upgrade
Other Geographies Revenue
516.60M502.30M
Log In
Log In
Log In
Upgrade
Revenue (Total)
2.74B2.78B
Log In
Log In
Log In
Upgrade

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2021
Period Ending
Jun '25 Dec '24 Dec '23 Jan '23 Jan '22 2014 - 2021
Labs Revenue
1.46B1.43B
Log In
Log In
Log In
Upgrade
Immunohematology Revenue
529.50M522.60M
Log In
Log In
Log In
Upgrade
Donor Screening Revenue
73.90M115.50M
Log In
Log In
Log In
Upgrade
Transfusion Medicine Revenue
603.40M638.10M
Log In
Log In
Log In
Upgrade
Point of Care Revenue
654.20M694.10M
Log In
Log In
Log In
Upgrade
Molecular Diagnostics Revenue
25.60M24.00M
Log In
Log In
Log In
Upgrade
Revenue (Total)
2.74B2.78B
Log In
Log In
Log In
Upgrade

Adjusted EBITDA by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2021
Period Ending
Jun '25 Dec '24 Dec '23 Jan '23 Jan '22 2014 - 2021
North America Adjusted EBITDA
-892.10M
Log In
Log In
Log In
Upgrade
EMEA Adjusted EBITDA
-46.50M
Log In
Log In
Log In
Upgrade
China Adjusted EBITDA
-130.50M
Log In
Log In
Log In
Upgrade
Other Geographies Adjusted EBITDA
-133.50M
Log In
Log In
Log In
Upgrade
Corporate Adjusted EBITDA
--659.70M
Log In
Log In
Log In
Upgrade
Operating Income (Other)
-233.50M-2.50B
Log In
Log In
Log In
Upgrade
Operating Income (Total)
-233.50M-1.96B
Log In
Log In
Log In
Upgrade
Updated Aug 5, 2025. Data Source: Fiscal.ai.